Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease
- PMID: 7162693
- DOI: 10.1016/0304-3940(82)90391-3
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease
Abstract
Choline acetyltransferase activity in discrete tissue punches from the nucleus of Meynert and in tissue from the temporal cortex was reduced by at least 90% and 75%, respectively, in 5 out of 6 elderly cases of Alzheimer's disease compared with 5 normal cases. In contrast, estimates of neurone density in these same cases revealed that there was only, on average, a 33% neurone loss in the nucleus of Meynert in Alzheimer's disease. These observations suggest that a key pathological change in Alzheimer's disease may be the 'down regulation' of transmitter-specific enzyme production in cholinergic neurones, and that neurone loss itself may be a secondary feature of the disease.
Similar articles
-
The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.Neurosci Lett. 1982 Feb 12;28(2):217-22. doi: 10.1016/0304-3940(82)90155-0. Neurosci Lett. 1982. PMID: 7070710
-
Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):936. doi: 10.1136/jnnp.45.10.936. J Neurol Neurosurg Psychiatry. 1982. PMID: 7143014 Free PMC article. No abstract available.
-
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.J Neurol Sci. 1982 Dec;57(2-3):407-17. doi: 10.1016/0022-510x(82)90045-4. J Neurol Sci. 1982. PMID: 7161627
-
Molecular forms of acetylcholinesterases in Alzheimer's disease.Fed Proc. 1986 Dec;45(13):2982-8. Fed Proc. 1986. PMID: 2430839 Review.
-
The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.Prog Brain Res. 1986;70:105-32. doi: 10.1016/s0079-6123(08)64300-9. Prog Brain Res. 1986. PMID: 3554348 Review. No abstract available.
Cited by
-
Heterologous expressing melittin in a probiotic yeast to evaluate its function for promoting NSC-34 regeneration.Appl Microbiol Biotechnol. 2024 Oct 28;108(1):496. doi: 10.1007/s00253-024-13336-7. Appl Microbiol Biotechnol. 2024. PMID: 39466458 Free PMC article.
-
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1985 May;48(5):413-21. doi: 10.1136/jnnp.48.5.413. J Neurol Neurosurg Psychiatry. 1985. PMID: 3998751 Free PMC article.
-
Dementia in the elderly: biochemical aspects.J R Coll Physicians Lond. 1984 Jan;18(1):25-7. J R Coll Physicians Lond. 1984. PMID: 6142949 Free PMC article. Review. No abstract available.
-
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease.Acta Neuropathol. 2015 Apr;129(4):527-40. doi: 10.1007/s00401-015-1392-5. Epub 2015 Jan 30. Acta Neuropathol. 2015. PMID: 25633602 Free PMC article. Review.
-
Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line.Proc Natl Acad Sci U S A. 1987 Aug;84(15):5474-7. doi: 10.1073/pnas.84.15.5474. Proc Natl Acad Sci U S A. 1987. PMID: 3474663 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical